About Regis Technologies
Regis Technologies is a company based in Morton Grove (United States) founded in 1956 was acquired by Esteve in July 2025.. The company has 107 employees as of December 31, 2021. Regis Technologies offers products and services including Custom API Development, cGMP Manufacturing, Chromatography Columns, and Specialty Reagents. Regis Technologies operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
- Headquarter Morton Grove, United States
- Employees 107 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Regis Technologies Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$229.74 K (USD), Grant
Jul 01, 2021
-
Investors
First AmBank
& 2 more
-
Employee Count
107
as on Dec 31, 2021
-
Acquired by
Esteve
(Jul 31, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Regis Technologies
Regis Technologies offers a comprehensive portfolio of products and services, including Custom API Development, cGMP Manufacturing, Chromatography Columns, and Specialty Reagents. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for developing and manufacturing pharmaceutical APIs.
Compliance-focused manufacturing for clinical and commercial APIs.
Specialized columns for HPLC and SFC separations.
Reagents for ion pairing and derivatizing in analysis.
Unlock access to complete
Funding Insights of Regis Technologies
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $229,741
-
First Round
First Round
(21 Dec 2005)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Grant - Regis Technologies | Valuation |
investors |
|
| Dec, 2005 | Amount | Debt – Conventional - Regis Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Regis Technologies
Regis Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include First AmBank, HHS and Esteve. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Commercial banking services are provided to businesses and individuals.
|
Founded Year | Domain | Location | |
|
Therapies for chronic pain treatment are developed by Esteve.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Regis Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Regis Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Regis Technologies Comparisons
Competitors of Regis Technologies
Regis Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| domain | founded_year | HQ Location |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| domain | founded_year | HQ Location |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provider of proprietary filtration solutions for life science
|
|
| domain | founded_year | HQ Location |
Small molecule analysis and purification services are provided using chromatography.
|
|
| domain | founded_year | HQ Location |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Regis Technologies
Frequently Asked Questions about Regis Technologies
When was Regis Technologies founded?
Regis Technologies was founded in 1956 and raised its 1st funding round 49 years after it was founded.
Where is Regis Technologies located?
Regis Technologies is headquartered in Morton Grove, United States. It is registered at Morton Grove, Illinois, United States.
Who is the current CEO of Regis Technologies?
Louis Glunz IV is the current CEO of Regis Technologies.
How many employees does Regis Technologies have?
As of Dec 31, 2021, the latest employee count at Regis Technologies is 107.
What does Regis Technologies do?
Regis Technologies offers synthesis, analytical and separation services to pharma companies to advance active pharmaceutical ingredient (API) and intermediates from initial process development and scale-up phases to final validation and commercial manufacturing. The company has special expertise in Supercritical Fluid Chromatography (SFC) and chiral compound development and separation. The companys service portfolio includes custom API and HPAPI manufacturing, analytical method development, cGMP non-GMP SFC separations, process research services (synthetic route modification and process validation) and quality control services. The company offers proprietary chromatography products with a special chiral emphasis.
Who are the top competitors of Regis Technologies?
Regis Technologies's top competitors include ChromaTan, Sepragen and Sepax Technologies.
What products or services does Regis Technologies offer?
Regis Technologies offers Custom API Development, cGMP Manufacturing, Chromatography Columns, and Specialty Reagents.
Who are Regis Technologies's investors?
Regis Technologies has 3 investors. Key investors include First AmBank, HHS, and Esteve.